Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2011 2
2014 2
2016 1
2017 9
2018 13
2019 12
2020 12
2021 26
2022 23
2023 27
2024 17
2025 29
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for liping zhong
Search for Luping Zhong instead (1 results)
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients.
Zhong L, Gan L, Wang B, Wu T, Yao F, Gong W, Peng H, Deng Z, Xiao G, Liu X, Na J, Xia D, Yu X, Zhang Z, Xiang B, Huo Y, Yan D, Dong Z, Fang F, Ma Y, Jin G, Su D, Liu X, Li Q, Liao H, Tang C, He J, Tang Z, Zhang S, Qiu B, Yang Z, Yang L, Chen Z, Zeng M, Feng R, Jiao J, Liao Y, Wang T, Wu L, Mi Z, Liu Z, Shi S, Zhang K, Shi W, Zhao Y. Zhong L, et al. Cell. 2025 Feb 20;188(4):1119-1136.e23. doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Cell. 2025. PMID: 39826543 Free article.
Therapeutic siRNA: state of the art.
Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ. Hu B, et al. Among authors: zhong l. Signal Transduct Target Ther. 2020 Jun 19;5(1):101. doi: 10.1038/s41392-020-0207-x. Signal Transduct Target Ther. 2020. PMID: 32561705 Free PMC article. Review.
Engineering a precise adenine base editor with minimal bystander editing.
Chen L, Zhang S, Xue N, Hong M, Zhang X, Zhang D, Yang J, Bai S, Huang Y, Meng H, Wu H, Luan C, Zhu B, Ru G, Gao H, Zhong L, Liu M, Liu M, Cheng Y, Yi C, Wang L, Zhao Y, Song G, Li D. Chen L, et al. Among authors: zhong l. Nat Chem Biol. 2023 Jan;19(1):101-110. doi: 10.1038/s41589-022-01163-8. Epub 2022 Oct 13. Nat Chem Biol. 2023. PMID: 36229683
Research progress of nanovaccine in anti-tumor immunotherapy.
Yao M, Liu X, Qian Z, Fan D, Sun X, Zhong L, Wu P. Yao M, et al. Among authors: zhong l. Front Oncol. 2023 Aug 24;13:1211262. doi: 10.3389/fonc.2023.1211262. eCollection 2023. Front Oncol. 2023. PMID: 37692854 Free PMC article. Review.
Study of Oncolytic Virus Preservation and Formulation.
Pan L, Liu X, Fan D, Qian Z, Sun X, Wu P, Zhong L. Pan L, et al. Among authors: zhong l. Pharmaceuticals (Basel). 2023 Jun 5;16(6):843. doi: 10.3390/ph16060843. Pharmaceuticals (Basel). 2023. PMID: 37375789 Free PMC article. Review.
177 results